Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Response and Safety in HIV Positive Subjects Co-infected With Hepatitis C Treated With a Kaletra Containing HAART Regimen

NCT00234975 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT00234975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Response and Safety in HIV Positive Subjects Co-infected With Hepatitis C Treated With a Kaletra Containing HAART Regimen
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2002
Completion date
January 31, 2008
Enrollment
86 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection